Huons Co., Ltd.
243070.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$221.38B
Close$
$-2871.36
115.9% downside
Current Fair Value
115.9% downsideOvervalued by 115.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $221.38 Billion |
|---|---|
| Enterprise Value | $331.67 Billion |
| Dividend Yield | $1170.00 (6.16%) |
| Earnings per Share | $3651.41 |
| Beta | 0.22 |
| Outstanding Shares | 11,980,000 |
Return
| Return on Equity | 5.12% |
|---|---|
| Return on Assets | 2.90% |
| Return on Invested Capital | 4.71% |
Valuation & Multiples
| P/E Ratio | 11.73 |
|---|---|
| PEG | -11.49 |
| Price to Sales | 0.36 |
| Price to Book Ratio | 0.53 |
| Enterprise Value to Revenue | 0.55 |
| Enterprise Value to EBIT | 15.21 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.48 |
| Debt to Equity | 0.43 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$112.57 B
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$109.30 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Huons Co., Ltd.
1,087 employees
CEO: Su-Young Song Huons Co., Ltd. operates as a global healthcare company, providing a broad spectrum of medical solutions designed to enhance human health in South Korea and worldwide. Its extensive product line includes a variety of oral solid medicatio...